Literature DB >> 20567185

From human papillomavirus to cervical cancer.

Mark Schiffman1, Nicolas Wentzensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20567185     DOI： 10.1097/AOG.0b013e3181e4629f

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  24 in total

1.  Evaluating the Use of LAST 2-Tiered Nomenclature and Its Impact on Reporting Cervical Lesions in a Population-Based Cancer Registry.

Authors:  Mei-Chin Hsieh; Elizabeth Van Dyne; Christina Lefante; Jean A Shapiro; Paran Pordell; Mary Anne Lynch; Natalie Gomez; Brent Mumphrey; Lauren Maniscalco; Rachna Jetly-Shridhar; Mona Saraiya; Xiao-Cheng Wu
Journal:  J Registry Manag       Date:  2019

Review 2.  Screening for Anal Cancer in Women.

Authors:  Anna-Barbara Moscicki; Teresa M Darragh; J Michael Berry-Lawhorn; Jennifer M Roberts; Michelle J Khan; Lori A Boardman; Elizabeth Chiao; Mark H Einstein; Stephen E Goldstone; Naomi Jay; Wendy M Likes; Elizabeth A Stier; Mark L Welton; Dorothy J Wiley; Joel M Palefsky
Journal:  J Low Genit Tract Dis       Date:  2015-07       Impact factor: 1.925

3.  Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.

Authors:  Alan G Waxman; David Chelmow; Teresa M Darragh; Herschel Lawson; Anna-Barbara Moscicki
Journal:  Obstet Gynecol       Date:  2012-12       Impact factor: 7.661

4.  Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years.

Authors:  Mark H Einstein; Mira Baron; Myron J Levin; Archana Chatterjee; Bradley Fox; Sofia Scholar; Jeffrey Rosen; Nahida Chakhtoura; Marie Lebacq; Robbert van der Most; Philippe Moris; Sandra L Giannini; Anne Schuind; Sanjoy K Datta; Dominique Descamps
Journal:  Hum Vaccin       Date:  2011-12-01

5.  Use of mobile telemedicine for cervical cancer screening.

Authors:  Kelly E Quinley; Rachel H Gormley; Sarah J Ratcliffe; Ting Shih; Zsofia Szep; Ann Steiner; Doreen Ramogola-Masire; Carrie L Kovarik
Journal:  J Telemed Telecare       Date:  2011-05-06       Impact factor: 6.184

6.  Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management.

Authors:  Nicolas Wentzensen; Joan Walker; Mark Schiffman; Hannah P Yang; Rosemary E Zuna; S Terence Dunn; R Andy Allen; Roy Zhang; Mark Sherman; Michael A Gold; Sophia S Wang
Journal:  Int J Cancer       Date:  2012-04-30       Impact factor: 7.396

7.  Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy.

Authors:  Julia W Gargano; Rosane Nisenbaum; Daisy R Lee; Mack T Ruffin; Martin Steinau; Ira R Horowitz; Lisa C Flowers; Talaat S Tadros; George Birdsong; Elizabeth R Unger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-25       Impact factor: 4.254

8.  Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.

Authors:  Nicolas Wentzensen; Lauren Schwartz; Rosemary E Zuna; Katie Smith; Cara Mathews; Michael A Gold; R Andy Allen; Roy Zhang; S Terence Dunn; Joan L Walker; Mark Schiffman
Journal:  Clin Cancer Res       Date:  2012-06-06       Impact factor: 12.531

9.  Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3.

Authors:  Hannah P Yang; Rosemary E Zuna; Mark Schiffman; Joan L Walker; Mark E Sherman; Lisa M Landrum; Katherine Moxley; Michael A Gold; S Terence Dunn; Richard A Allen; Roy Zhang; Rodney Long; Sophia S Wang; Nicolas Wentzensen
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

10.  Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping.

Authors:  Shichao Ge; Bo Gong; Xushan Cai; Xiaoer Yang; Xiaowei Gan; Xinghai Tong; Haichuan Li; Meijuan Zhu; Fengyun Yang; Hongrong Zhou; Guofan Hong
Journal:  Cancer Med       Date:  2012-07-05       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.